Danaher Corp (DHR) Stock Price Prediction

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, D.C. and currently employs 58,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables, and services that are primarily used by customers to advance and accelerate the research, development, manufacture, and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services, and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acids, proteins, metabolites, and cells. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions.